Dear Colleague,

GTC is proud to present the Biomarker Partnering and Deal-Making Conference as part of the Biomarker Summit 2012 - the only conference bridging the biomarker scientific and business & investment communities.

Closing in on becoming a $13 billion industry, biomarker advancements require new investments while offering the potential for significant returns. While both developers and investors are seeking the strongest partnerships, only those with the deepest understanding of both scientific and business issues will succeed.

Offering a unique opportunity, the Biomarker Partnering and Deal-Making Conference assembles leading players to discuss what needs to be accomplished to lead the industry into its next phase. The business of biomarkers has reached an exciting and critical stage and intelligence and strategic relationship building is more important than ever. Attendees will be able to set the stage for both at this leading event.

Beyond simply attending a conference, attendees will be part of the larger Biomarker Summit 2012 that also includes:

Biomarker and Diagnostics Conference
4th Oncology Biomarker Conference
6th Biomarker Development Conference

Limitless networking opportunities will be provided for attendees across all four Summit tracks. We look forward to welcoming you to the Biomarker Summit 2012!

Attend ALL 2012 GTCbio Conferences for only $3995 industry rate or $1990 acad/govt rate. Click here to sign up!